ProGreen Properties (OTCMKTS:PGUS) & Hyperion DeFi (NASDAQ:HYPD) Financial Review

Hyperion DeFi (NASDAQ:HYPD) and ProGreen Properties (OTCMKTS:PGUS) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Valuation & Earnings

This table compares Hyperion DeFi and ProGreen Properties”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$1.40 million	30.63	-$45.31 million	($6.53)	-0.42
ProGreen Properties	N/A	N/A	N/A	N/A	N/A

ProGreen Properties has lower revenue, but higher earnings than Hyperion DeFi.

Profitability

This table compares Hyperion DeFi and ProGreen Properties’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-13.93%	-11.60%
ProGreen Properties	N/A	N/A	N/A

Insider and Institutional Ownership

25.8% of Hyperion DeFi shares are held by institutional investors. 7.5% of Hyperion DeFi shares are held by company insiders. Comparatively, 4.3% of ProGreen Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Hyperion DeFi and ProGreen Properties, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	2	0	2	0	2.00
ProGreen Properties	0	0	0	0	0.00

Hyperion DeFi currently has a consensus target price of $7.20, suggesting a potential upside of 160.78%. Given Hyperion DeFi’s stronger consensus rating and higher possible upside, analysts plainly believe Hyperion DeFi is more favorable than ProGreen Properties.

Summary

Hyperion DeFi beats ProGreen Properties on 7 of the 9 factors compared between the two stocks.

About Hyperion DeFi

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

About ProGreen Properties

ProGreen US, Inc., together with its subsidiaries, focuses on agricultural operations and residential real estate development activities in Baja California, Mexico. The company was formerly known as ProGreen Properties, Inc. and changed its name to ProGreen US, Inc. in July 2016. ProGreen US, Inc. was founded in 1982 and is based in San Diego, California.